The Drug and Device blog has an interesting post today on rulings on some unusual motions in limine in a drug case. The issues include a ruling on emails among members of an advisory panel, and whether they are admissions of the company.
top of page
The Intersection Among Torts, Science, Corporate Law, Insurance & Bankruptcy
GlobalTort
Search
Recent Posts
See AllThe litigation industry continues to evolve and grow. Consider, for example, this June 19, 2019 press release by a group of firms brining...
For those litigating drug cases, the NEJM just published an open access article with a broad set of data on medical marketing. It’s...
A cogent summary of statutes of repose for drugs and devices is online at a July 16, 2018 guest post at Drug & Device blog.
bottom of page
Commenti